Efavirenz Completed Phase 3 Trials for Human Immunodeficiency Virus (HIV) Infections Screening

IndicationsStatusPurposePhase
CompletedScreening3
clinicaltrials.gov IdentifierTitleDrugs
NCT01271894The Intensive Pharmacokinetics Sub-study of Encore1 (ENCORE1-PK)